Content about PITTSBURGH

July 25, 2011

Discount grocery chain Bottom Dollar Food announced plans to enter the greater Pittsburgh and Youngstown, Ohio, markets.

SALISBURY, N.C. — Discount grocery chain Bottom Dollar Food announced plans to enter the greater Pittsburgh and Youngstown, Ohio, markets.

The expansion includes 14 stores that will open in 2012 and is said to create more than 600 jobs.

July 19, 2011

Generic drug maker Mylan is looking for a bigger place to call home, according to published reports.

PITTSBURGH — Generic drug maker Mylan is looking for a bigger place to call home, according to published reports.

The Pittsburgh Business Times reported that Mylan was planning to move from its current 96,000-sq.-ft. headquarters in Southpointe, a development in the Pittsburgh suburb of Cecil Township, to a 250,000-sq.-ft. building nearby.

The new headquarters is under construction, the newspaper reported.

July 14, 2011

Giant Eagle on Thursday unveiled its first two compressed natural gas fueling stations in the Pittsburgh area at its Beechnut Drive retail support and distribution center.

PITTSBURGH — Giant Eagle on Thursday unveiled its first two compressed natural gas fueling stations in the Pittsburgh area at its Beechnut Drive retail support and distribution center.

July 13, 2011

GNC on Tuesday continued its management makeover with the promotions of Jeffrey Hennion and Darryl Green and the announced resignation of COO David Berg.

PITTSBURGH — GNC on Tuesday continued its management makeover with the promotions of Jeffrey Hennion and Darryl Green and the announced resignation of COO David Berg.

The specialty retailer last week named Thomas Dowd, a 22-year GNC veteran, the company’s chief merchandising officer following the departure of Beth Kaplan, former president and chief merchandising officer. It also was announced last week that GNC CEO Joe Fortunato would assume the role of president.

July 5, 2011

Thomas Dowd has been named GNC EVP, chief merchandising officer and general manager, the company announced in a Securities and Exchange Commission filing Friday.

PITTSBURGH — Thomas Dowd has been named GNC EVP, chief merchandising officer and general manager, the company announced in a Securities and Exchange Commission filing Friday.

Dowd has served as EVP store operations and development since April 2007.

The move follows the announcement in June that Beth Kaplan would be stepping down from her role as GNC president and chief merchandising officer. Following that announcement, GNC CEO Joe Fortunato reassumed his role of president.

June 28, 2011

American Beverage has reformulated its Little Hug Fruit Barrels beverage line for kids.

PITTSBURGH — American Beverage has reformulated its Little Hug Fruit Barrels beverage line for kids.

The drinks now tout just 10 calories and have been fortified with vitamins B and E. Additionally, Little Hug Fruit Barrels' packaging has been updated to feature bright colors and a new brand logo.

June 21, 2011

General Nutrition Centers announced that its president and chief merchandising officer has resigned.

PITTSBURGH — General Nutrition Centers announced that its president and chief merchandising officer has resigned.

Beth Kaplan, who served in the role for 3.5 years, is leaving the company to pursue personal interests. As a member of the senior management team, Kaplan helped the company prepare for its recent initial public offering.

The role of president will be reassumed by GNC CEO Joe Fortunato.

June 20, 2011

Mylan has scored a victory in its efforts to make a generic version of a Teva drug for multiple sclerosis.

PITTSBURGH — Mylan has scored a victory in its efforts to make a generic version of a Teva drug for multiple sclerosis.

The U.S. District Court for the Southern District of New York denied Teva’s motion for a summary judgment finding no inequitable conduct in relation to Copaxone (glatiramer acetate).

June 8, 2011

Target’s board has finalized the decision to locate the company’s Canadian headquarters in Mississauga, Ontario, said president, chairman and CEO Gregg Steinhafel at a shareholders meeting in Pittsburgh on Wednesday.

NEW YORK — Target’s board has finalized the decision to locate the company’s Canadian headquarters in Mississauga, Ontario, said president, chairman and CEO Gregg Steinhafel at a shareholders meeting in Pittsburgh on Wednesday.

June 7, 2011

Another generic drug maker has been given the green light to market its version of an Alzheimer's disease treatment.

PITTSBURGH — Another generic drug maker has been given the green light to market its version of an Alzheimer's disease treatment.

Mylan said that its subsidiary, Matrix Labs, has received final approval from the Food and Drug Administration to manufacture and market donepezil hydrochloride tablets in 5-mg and 10-mg strengths. The drug, a generic version of Pfizer and Eisai's Aricept, is used to treat dementia associated with Alzheimer's disease. Mylan said it will launch the product immediately.

June 2, 2011

The Food and Drug Administration has approved a generic drug for depression and anxiety made by Mylan, the drug maker said Thursday.

PITTSBURGH — The Food and Drug Administration has approved a generic drug for depression and anxiety made by Mylan, the drug maker said Thursday.

Mylan announced the approval of venlafaxine hydrochloride extended-release capsules in the 37.5-mg, 75-mg and 150-mg strengths.

The drug, used to treat major depressive disorder and social anxiety disorder, is a generic version of Effexor XR, made by Wyeth. Mylan is launching the drug under a licensing agreement it made with Wyeth before its purchase by Pfizer.

May 31, 2011

Generic drug maker Mylan plans to give one of its subsidiaries a new name, the company said.

PITTSBURGH — Generic drug maker Mylan plans to give one of its subsidiaries a new name, the company said.

May 26, 2011

General Nutrition Centers has added PayPal's Mobile Express Checkout to its mobile site.

PITTSBURGH — General Nutrition Centers has added PayPal's Mobile Express Checkout to its mobile site.

The integration exclusively was made by mobile and social commerce provider Branding Brand without any involvement from third-party service providers, and makes GNC one of the first to implement this feature on its mobile site.

May 25, 2011

Mylan has launched a generic version of an opioid painkiller, the company said Wednesday.

PITTSBURGH — Mylan has launched a generic version of an opioid painkiller, the company said Wednesday.

Mylan announced the launch of oxycodone hydrochloride tablets in the 5-mg, 15-mg and 30-mg strengths. Mylan is launching the drug under a development and supply agreement with Coastal Pharmaceuticals.

The drug is a generic version of Xanodyne’s Roxicodone, a treatment for moderate to severe pain. Oxycodone hydrochloride tablets had sales of about $325 million during the 12-month period ended in March, according to IMS Health.

May 23, 2011

GNC on Monday announced an exclusive licensing agreement with Shadow Beverages and Snacks, the producer and distributor of Ironclad Energy + Hydration and No Fear Energy drinks.

PITTSBURGH — GNC on Monday announced an exclusive licensing agreement with Shadow Beverages and Snacks, the producer and distributor of Ironclad Energy + Hydration and No Fear Energy drinks.

The deal is expected to push the GNC brand name beyond its retail base and partnership with Rite Aid in the drug channel. Under the terms of the licensing agreement, Shadow Beverages and Snacks will produce a line of ready-to-drink products that will be marketed under the GNC brand.

May 23, 2011

The Food and Drug Administration has approved a generic drug for epilepsy made by Mylan.

PITTSBURGH — The Food and Drug Administration has approved a generic drug for epilepsy made by Mylan.

Mylan said Monday that the FDA had approved its divalproex sodium capsules in the 125-mg strength. The drug is a generic version of Abbott’s Depakote Sprinkle capsules and is used to treat certain types of epileptic seizures.

Divalproex sodium capsules had sales of about $89 million during the 12-month period ended in March, according to IMS Health.

May 16, 2011

Drug maker Mylan has launched a generic treatment for muscle spasms, the company said Friday.

PITTSBURGH — Drug maker Mylan has launched a generic treatment for muscle spasms, the company said Friday.

Mylan announced the launch of cyclobenzaprine hydrochloride, a once-daily muscle relaxant, in the 15-mg and 30-mg strengths. The drug is a generic version of Cephalon’s Amrix, which had sales of about $125 million during the 12-month period ended in March, according to IMS Health.

May 10, 2011

Heinz has given a nod to the past by packaging its ketchup in classic glass bottles.

PITTSBURGH — Heinz has given a nod to the past by packaging its ketchup in classic glass bottles.

Limited-edition glass bottles of Heinz tomato ketchup will be available in a 14-oz. size for a suggested retail price of $1.99 at select retailers, including Walmart and Safeway, now through August, Heinz said Tuesday.

May 6, 2011

Giant Eagle is celebrating its locally and regionally grown produce with a new video on its website.

PITTSBURGH — Giant Eagle is celebrating its locally and regionally grown produce with a new video on its website.

The retailer said that it is taking several steps to educate consumers on which fruits and vegetables are at their peak season throughout the year, and is further relaying this message through its video, which can be viewed on the company's website.

May 3, 2011

Sales at generic drug maker Mylan increased by 12% during first quarter 2011, compared with first quarter 2010, the company said Tuesday.

PITTSBURGH — Sales at generic drug maker Mylan increased by 12% during first quarter 2011, compared with first quarter 2010, the company said Tuesday.

Sales for the three months ended March 31 were $1.45 billion, compared with $1.29 billion during the same period a year ago. Profits, meanwhile, were $104.2 million, compared with $61.1 million in first quarter 2010.

April 25, 2011

You can’t be all things to all people, but you can be all things to one person. That’s the opportunity Giant Eagle is grabbing with the number of ways the Pittsburgh food-and-pharmacy retailer interacts with patients. 


“Our goal is to help those within our communities live healthier, longer lives,” Dan Donovan, Giant Eagle spokesman, told Drug Store News. “We look to do this in a number of ways … [through] initiatives, such as our health and beauty care business, in-store retail health clinics and our group of skilled dietitians.”


April 25, 2011

Mylan has launched a generic treatment for breast cancer, the drug maker said Monday.

PITTSBURGH — Mylan has launched a generic treatment for breast cancer, the drug maker said Monday.

Mylan announced the launch of letrozole tablets in the 2.5-mg strength, an adjuvant treatment for postmenopausal women with hormone receptor-positive early-stage breast cancer.

The drug is the first generic version of Novartis’ Femara, which had sales of about $682 million in 2010, according to IMS Health.

April 20, 2011

Mylan has launched a generic drug for treating herpes, the company said Wednesday.

PITTSBURGH — Mylan has launched a generic drug for treating herpes, the company said Wednesday.

Mylan announced the launch of famciclovir tablets in the 125-mg, 250-mg and 500-mg strengths. The drug is a generic version of Novartis’ Famvir.

Branded and generic versions of the drug had sales of $196 million in 2010, according to IMS Health.

April 7, 2011

GNC Holdings on Wednesday announced the closing of its initial public offering of 25.9 million shares of its Class A common stock at a public offering price of $16 per share. GNC's Class A common stock began trading Friday, April 1, on the New York Stock Exchange under the ticker symbol "GNC."

PITTSBURGH — GNC Holdings on Wednesday announced the closing of its initial public offering of 25.9 million shares of its Class A common stock at a public offering price of $16 per share. GNC's Class A common stock began trading Friday, April 1, on the New York Stock Exchange under the ticker symbol "GNC."

April 5, 2011

Mylan subsidiary Bioniche Pharma has launched an injectable treatment for a rare metabolic disorder, Mylan said Tuesday.

PITTSBURGH — Mylan subsidiary Bioniche Pharma has launched an injectable treatment for a rare metabolic disorder, Mylan said Tuesday.

Mylan announced the launch of octreotide acetate injection in prefilled syringes, a generic version of Novartis’ Sandostatin, used to treat the disorder acromegaly and suppress or inhibit severe diarrhea related to certain tumors. Acromegaly results from excess growth hormone produced in the pituitary gland, causing fatigue and weakness, body odor and carpal tunnel syndrome.